Combined data from two phase III trials of the NK1 antagonist aprepitant plus a 5HT3 antagonist and a corticosteroid for prevention of chemotherapy-induced nausea and vomiting: Effect of gender on treatment response

P. J. Hesketh, S. M. Grunberg, J. Herrstedt, R. De Wit, R. J. Gralla, A. D. Carides, A. Taylor, J. K. Evans, K. J. Horgan

Research output: Contribution to journal › Article › peer-review

82 Scopus citations

Fingerprint

Dive into the research topics of 'Combined data from two phase III trials of the NK1 antagonist aprepitant plus a 5HT3 antagonist and a corticosteroid for prevention of chemotherapy-induced nausea and vomiting: Effect of gender on treatment response'. Together they form a unique fingerprint.

Medicine & Life Sciences